AAV recombineering with single strand oligonucleotides

No prior work had resolved how to control the random joining of viral genomes during gene delivery. It was already known that Adeno-associated virus (AAV) particles trigger a temporary cellular response to damaged DNA. Host proteins typically transform linear viral strands into circular structures or long chains known as concatemers. These natural joining events occur without a specific pattern, leading to unpredictable genome arrangements. That uncertainty drove the need for a strategy to guide these molecular interactions. Prior research has shown that inverted terminal repeats play a role in these spontaneous joining processes. However, the low probability of achieving a specific orientation remains a significant hurdle for therapeutic applications. This gap motivated the development of a method to direct viral genome assembly.

The primary aim of this work is to establish a method for controlling the orientation of viral genome concatemerization. Researchers sought to address the inherent unpredictability of how viral strands join within host cells. Natural joining processes often result in random arrangements, which limits the efficiency of gene delivery systems. The team hypothesized that providing a synthetic template could guide these molecular repair events. They focused on creating a bridge between separate viral genomes to force a specific junction sequence. This motivation stems from the need to improve the reliability of viral vectors for therapeutic purposes. The study explores whether single-strand DNA oligonucleotides can effectively direct this recombination in human cells. By resolving this challenge, the authors hope to provide a new tool for manipulating viral DNA structures.

The investigators developed a novel technique termed Oligo-Assisted AAV Genome Recombination to manipulate viral assembly. They utilized human cell lines to test the efficacy of directing genome joining. The team introduced synthetic single-strand DNA oligonucleotides designed with specific homology to viral sequences. These molecules were delivered alongside viral particles to facilitate the formation of intermolecular bridges. The researchers analyzed the resulting genomic junctions to determine the orientation of the joined viral strands. They compared the outcomes of OAGR against spontaneous joining events to quantify the improvement in precision. The team also examined the influence of different oligonucleotide configurations on the success of the recombination. Finally, they assessed whether the process was dependent on the state of the viral genome by testing both single-strand and duplexed inputs.

The researchers demonstrated that OAGR successfully directs concatemerization to a desired orientation in human cells. This approach significantly improves upon the natural, unbiased process where the likelihood of a specific orientation is less than 1 in 6. The study confirmed that the synthetic oligonucleotides form an intermolecular bridge that dictates the sequence of the genomic junctions. The team observed that OAGR is strictly limited to single-strand viral genomes, indicating a requirement for replication-dependent recombination. Furthermore, the experiments revealed clear polarity biases in all tested configurations. The only exception occurred when the oligonucleotide targeted the inverted terminal repeats of the virus. These results provide evidence that synthetic DNA can override the inherent randomness of viral genome joining. The data show that the method achieves precise control over the structural arrangement of the viral DNA.

The researchers propose that OAGR provides a reliable way to influence the structural arrangement of viral genomes. Their findings suggest that this technique relies on replication-dependent pathways within the host cell. The authors note that the observed polarity biases highlight the specific requirements for successful intermolecular joining. This synthesis indicates that the method is restricted to single-strand viral inputs rather than duplexed forms. The study implies that directing these junctions could enhance the utility of viral vectors for large gene therapy. The authors conclude that their approach offers a valuable tool for studying the fundamental mechanisms of homologous recombination. These results demonstrate that synthetic DNA bridges can effectively bypass the random nature of viral concatemerization. The work establishes a foundation for future investigations into precise viral genome engineering.